35 years experience in Chief Financial Officer roles in various biopharmaceutical companies including Oncosec (NASDAQ: ONCS), Biological Dynamics and Genmark Diagnostics (NASDAQ: GNMK)
35 years experience in Chief Financial Officer roles in various biopharmaceutical companies including Oncosec (NASDAQ: ONCS), Biological Dynamics and Genmark Diagnostics (NASDAQ: GNMK)